CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-19 | Virgin Herbert EVP, Research & CSO | Sale | −1,755 | $38.00 | $67K | 0 |
| 2020-06-19 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −3,510 | 538,875 | ||
| 2020-06-17 | Pang Phillip Chief Medical Officer | Option exercise | +12,500 | $5.18 | $65K | 28,277 |
| 2020-06-17 | Pang Phillip Chief Medical Officer | Sale | −5,000 | $37.27 | $186K | 23,277 |
| 2020-06-17 | Pang Phillip Chief Medical Officer | Sale | −7,500 | $37.26 | $279K | 15,777 |
| 2020-06-17 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −12,500 | 86,110 | ||
| 2020-06-09 | Virgin Herbert EVP, Research & CSO | Option exercise | +3,805 | $1.53 | $6K | 3,805 |
| 2020-06-09 | Virgin Herbert EVP, Research & CSO | Sale | −3,805 | $36.28 | $138K | 0 |
| 2020-06-09 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −3,805 | 542,385 | ||
| 2020-06-03 | Pang Phillip Chief Medical Officer | Option exercise | +12,500 | $5.18 | $65K | 28,277 |
| 2020-06-03 | Pang Phillip Chief Medical Officer | Sale | −5,000 | $35.09 | $175K | 23,277 |
| 2020-06-03 | Pang Phillip Chief Medical Officer | Sale | −7,500 | $35.06 | $263K | 15,777 |
| 2020-06-03 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −12,500 | 98,610 | ||
| 2020-06-01 | Parrish Jay Chief Business Officer | Option exercise | +75,000 | $1.49 | $111K | 297,222 |
| 2020-06-01 | Parrish Jay Chief Business Officer | Sale | −75,000 | $35.22 | $2.6M | 222,222 |
| 2020-06-01 | Parrish Jay Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −75,000 | 72,221 | ||
| 2020-06-01 | Horn Howard CFO | Sale | −3,286 | $34.53 | $113K | 274,491 |
| 2020-06-01 | Horn Howard CFO | Sale | −6,714 | $35.38 | $238K | 267,777 |
| 2020-05-26 | Virgin Herbert EVP, Research & CSO | Option exercise | +3,805 | $1.53 | $6K | 3,805 |
| 2020-05-26 | Virgin Herbert EVP, Research & CSO | Sale | −3,805 | $34.08 | $130K | 0 |
Page 55 of 61 · 1,204 trades